Acute liver failure.

Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr (2010) 1.29

Innate immune dysfunction in acute and chronic liver disease. Wien Klin Wochenschr (2009) 0.96

Pertussis toxin, an inhibitor of G(αi) PCR, inhibits bile acid- and cytokine-induced apoptosis in primary rat hepatocytes. PLoS One (2012) 0.77

Saccadic latency in hepatic encephalopathy: a pilot study. Metab Brain Dis (2010) 0.76

Inhibitory effect of oxymatrine on hepatocyte apoptosis via TLR4/PI3K/Akt/GSK-3β signaling pathway. World J Gastroenterol (2017) 0.75

Bridging to transplantation in acute liver failure in a 7-month-old infant. Wien Klin Wochenschr (2006) 0.75

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38

Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med (1996) 9.97

Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med (2003) 5.92

Acute liver failure: redefining the syndromes. Lancet (1993) 4.99

The management of fulminant hepatic failure. Prog Liver Dis (1970) 4.37

Global control of hepatitis B virus infection. Lancet Infect Dis (2002) 3.74

Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet (2002) 3.73

Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ (1991) 2.94

Acetaminophen poisoning and toxicity. Pediatrics (1975) 2.71

Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology (2003) 2.71

The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med (2003) 2.59

The systemic inflammatory response syndrome in acute liver failure. Hepatology (2000) 2.47

Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med (2000) 2.40

Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis (1986) 2.39

Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci U S A (2003) 2.34

Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology (2002) 2.33

Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology (1996) 2.18

Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ (1990) 2.18

Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet (1998) 2.06

Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99

Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet (1999) 1.89

Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl (2000) 1.88

Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet (1993) 1.87

Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol (2000) 1.64

Effects of hypothermia on brain glucose metabolism in acute liver failure: a H/C-nuclear magnetic resonance study. Gastroenterology (2003) 1.60

Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology (2000) 1.53

Increased intracranial pressure in a porcine model of fulminant hepatic failure using amatoxin and endotoxin. J Hepatol (2001) 1.52

Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology (2003) 1.52

Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol (2002) 1.49

Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology (2000) 1.49

Cerebral hyperemia and nitric oxide synthase in rats with ammonia-induced brain edema. J Hepatol (2001) 1.47

Maternal and perinatal outcome in severe pregnancy-related liver disease. Hepatology (1997) 1.47

S-100b and neuron-specific enolase in patients with fulminant hepatic failure. Liver Transpl (2001) 1.43

Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut (1981) 1.43

Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology (1999) 1.42

Emergency treatment of neonatal hyperammonaemic coma with mild systemic hypothermia. Lancet (2001) 1.41

Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) (2003) 1.31

Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology (2000) 1.19

The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology (2002) 1.19

Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis (2003) 1.18

High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg (2003) 1.14

Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl (2003) 1.14

Extracorporeal liver perfusion system for successful hepatic support pending liver regeneration or liver transplantation: a pre-clinical controlled trial. Transplantation (1999) 1.12

The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage. Clin Pharmacol Ther (2002) 1.10

Auxiliary versus orthotopic liver transplantation for acute liver failure. EURALT Study Group. European Auxiliary Liver Transplant Registry. J Hepatol (1999) 1.06

Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation (1999) 1.04

Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis (2001) 1.01

Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology (1999) 1.01

The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim Biophys Acta (2002) 1.00

The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol (1993) 1.00

Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal. Am J Physiol (1998) 0.99

Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial. Hepatology (1987) 0.98

Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int (2004) 0.97

Beneficial effects of n-acetylcysteine on ischaemic brain injury. Br J Pharmacol (2000) 0.96

Treatment of severe liver failure with a bioartificial liver. Ann N Y Acad Sci (1997) 0.95

Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol (1999) 0.95

Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease. Biochem Pharmacol (2003) 0.95

Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol (1986) 0.95

Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology (2000) 0.95

Earlier identification of patients at risk from acetaminophen-induced acute liver failure. Crit Care Med (1998) 0.95

Hepatitis induced by Kava (Piper methysticum rhizoma). J Hepatol (2003) 0.93

Timing and aetiology of bacterial infections in a liver intensive care unit. J Hosp Infect (2003) 0.93

Prospective study comparing the efficacy of prophylactic parenteral antimicrobials, with or without enteral decontamination, in patients with acute liver failure. Liver Transpl Surg (1996) 0.93

The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int (2003) 0.92

Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet (1993) 0.92

The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology (1993) 0.91

Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis. J Hepatol (1998) 0.90

Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus). Wien Klin Wochenschr (2003) 0.88

Acute hepatitis A virus infection: a review of prognostic factors from 25 years experience in a tertiary referral center. Hepatogastroenterology (2002) 0.87

L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatology (1999) 0.87

Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure. Hepatology (1995) 0.87

Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci (2000) 0.86

Five cases of fulminant hepatitis due to herpes simplex virus in adults. Dig Dis Sci (2002) 0.84

The impact of current tobacco use on the outcome of paracetamol poisoning. Aliment Pharmacol Ther (2003) 0.84

Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver. Gut (2003) 0.83

Classifying acute liver failure. Lancet (1993) 0.83

Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis. Hepatology (2001) 0.83

Determinants of ammonia clearance by hemodialysis. Artif Organs (1996) 0.83

Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients. Transplant Proc (2001) 0.82

Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure. J Hepatol (1998) 0.82

Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc (2002) 0.80

Human herpesvirus-6 and acute liver failure. Transplantation (2003) 0.80

Brain edema and portal-systemic encephalopathy. Liver Transpl (2000) 0.79

Liver support in acute liver failure. Wien Klin Wochenschr (2003) 0.78

Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin. Hepatology (1997) 0.78

Immunotoxicology of the liver: adverse reactions to drugs. J Hepatol (1997) 0.78

Acute hepatic failure and lactate acidosis associated with antiretroviral treatment for HIV. Wien Klin Wochenschr (2003) 0.77

The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells. Artif Organs (1998) 0.77

Brain edema and intracranial hypertension in rats after total hepatectomy. Gastroenterology (1995) 0.77

Fulminant hepatitis in patients with chronic liver disease. J Viral Hepat (2000) 0.77

Hepatocyte liver-assist systems--a clinical update. Mayo Clin Proc (1998) 0.77

Serial recording of sensory evoked potentials: a noninvasive prognostic indicator in fulminant liver failure. Hepatology (1994) 0.76

Vasopressin accelerates experimental ammonia-induced brain edema in rats after portacaval anastomosis. J Hepatol (2003) 0.76

Reduced serum Gc-globulin concentrations in patients with fulminant hepatic failure: association with multiple organ failure. Crit Care Med (1997) 0.76